Su‐Ann Yeoh

531 total citations
16 papers, 122 citations indexed

About

Su‐Ann Yeoh is a scholar working on Rheumatology, Genetics and Pathology and Forensic Medicine. According to data from OpenAlex, Su‐Ann Yeoh has authored 16 papers receiving a total of 122 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Rheumatology, 4 papers in Genetics and 3 papers in Pathology and Forensic Medicine. Recurrent topics in Su‐Ann Yeoh's work include Chronic Lymphocytic Leukemia Research (4 papers), Rheumatoid Arthritis Research and Therapies (4 papers) and Systemic Lupus Erythematosus Research (3 papers). Su‐Ann Yeoh is often cited by papers focused on Chronic Lymphocytic Leukemia Research (4 papers), Rheumatoid Arthritis Research and Therapies (4 papers) and Systemic Lupus Erythematosus Research (3 papers). Su‐Ann Yeoh collaborates with scholars based in United Kingdom, United States and Australia. Su‐Ann Yeoh's co-authors include Emma Denneny, Chris Wincup, David Isenberg, Michael R. Ehrenstein, Robin Taylor, Sarah L. Price, Irene Nobeli, Andrew Embleton-Thirsk, Christine Fox and R G Hull and has published in prestigious journals such as Chemical Physics Letters, Annals of the Rheumatic Diseases and Lara D. Veeken.

In The Last Decade

Su‐Ann Yeoh

16 papers receiving 120 citations

Peers

Su‐Ann Yeoh
Jiacai Cho Singapore
Su‐Ann Yeoh
Citations per year, relative to Su‐Ann Yeoh Su‐Ann Yeoh (= 1×) peers Jiacai Cho

Countries citing papers authored by Su‐Ann Yeoh

Since Specialization
Citations

This map shows the geographic impact of Su‐Ann Yeoh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Su‐Ann Yeoh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Su‐Ann Yeoh more than expected).

Fields of papers citing papers by Su‐Ann Yeoh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Su‐Ann Yeoh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Su‐Ann Yeoh. The network helps show where Su‐Ann Yeoh may publish in the future.

Co-authorship network of co-authors of Su‐Ann Yeoh

This figure shows the co-authorship network connecting the top 25 collaborators of Su‐Ann Yeoh. A scholar is included among the top collaborators of Su‐Ann Yeoh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Su‐Ann Yeoh. Su‐Ann Yeoh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
2.
Chock, Yu Pei Eugenia, Michael Putman, Richard Conway, et al.. (2022). Experience with telemedicine amongst rheumatology clinicians during the COVID-19 pandemic: an international survey. Rheumatology Advances in Practice. 6(2). rkac039–rkac039. 8 indexed citations
3.
Yeoh, Su‐Ann, et al.. (2021). The synergistic efficacy of hydroxychloroquine with methotrexate is accompanied by increased erythrocyte mean corpuscular volume. Lara D. Veeken. 61(2). 787–793. 6 indexed citations
4.
Yeoh, Su‐Ann, et al.. (2021). Early reduction in circulating monocyte count predicts maintenance of remission in patients with rheumatoid arthritis treated with anti-TNF therapy. Annals of the Rheumatic Diseases. 80(12). 1628–1629. 4 indexed citations
5.
Yeoh, Su‐Ann, et al.. (2021). Patient and public involvement in rheumatology research: embracing the wave of change. The Lancet Rheumatology. 3(8). e540–e542. 3 indexed citations
6.
Yeoh, Su‐Ann, et al.. (2021). Lupus and the Lungs: The Assessment and Management of Pulmonary Manifestations of Systemic Lupus Erythematosus. Frontiers in Medicine. 7. 610257–610257. 50 indexed citations
7.
Yeoh, Su‐Ann, et al.. (2021). Advances in systemic lupus erythematosus. Medicine. 50(1). 7–17. 3 indexed citations
8.
Hawkins, Eleanor C., et al.. (2021). P074 Insights into creating a virtual patient and public involvement initiative. Lara D. Veeken. 60(Supplement_1). 1 indexed citations
9.
Yeoh, Su‐Ann & Michael R. Ehrenstein. (2020). Are treat-to-target and dose tapering strategies for rheumatoid arthritis possible during the COVID-19 pandemic?. The Lancet Rheumatology. 2(8). e454–e456. 2 indexed citations
11.
Yeoh, Su‐Ann, et al.. (2020). AB0326 REAL-WORLD EXPERIENCE ON SWITCHING ADALIMUMAB ORIGINATOR TO BIOSIMILAR IN INFLAMMATORY ARTHRITIS – A RETROSPECTIVE STUDY. Annals of the Rheumatic Diseases. 79. 1462–1462. 1 indexed citations
12.
Yeoh, Su‐Ann, et al.. (2020). An unfavourable outcome following switching intravenous abatacept and tocilizumab to subcutaneous forms during the COVID-19 pandemic. Lara D. Veeken. 60(2). 977–979. 6 indexed citations
13.
Yeoh, Su‐Ann, et al.. (2018). Advances in systemic lupus erythematosus. Medicine. 46(2). 84–92. 16 indexed citations
14.
Yeoh, Su‐Ann, Christine Fox, & R G Hull. (2016). Neutropenia in the Elderly: A Rheumatology Perspective. Drugs & Aging. 33(8). 585–601. 3 indexed citations
15.
Nobeli, Irene, Su‐Ann Yeoh, Sarah L. Price, & Robin Taylor. (1997). On the hydrogen bonding abilities of phenols and anisoles. Chemical Physics Letters. 280(3-4). 196–202. 10 indexed citations
16.
Yeoh, Su‐Ann, et al.. (1967). Fabry's disease with renal tubular acidosis.. PubMed. 8(4). 275–9. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026